- Global Pharma News & Resources

Press Releases - 2019-11-08

Date Title Company
08-Nov-2019 FDA approves first therapy to treat patients with rare blood disorder U.S. Food and Drug Administration
08-Nov-2019 Akeso, Inc. Completes Series-D Private Financing for US$150 Million Akeso, Inc.
08-Nov-2019 BioNTech to Report Third Quarter 2019 Financial Results and Operational Progress on November 14, 2019 BioNTech SE
08-Nov-2019 Mallinckrodt Announces UVADEX® (Methoxsalen) Approved in Australia for use with the THERAKOS® CELLEX® Photopheresis System for Treatment of Chronic Graft Versus Host Disease (cGvHD) and Skin Manifestations of Cutaneous T-Cell Lymphoma (CTCL) in Mallinckrodt plc
08-Nov-2019 Pooled Analyses of Bempedoic Acid Phase 3 LDL-C Lowering Clinical Trial Programme to be Presented at the American Heart Association 2019 Scientific Sessions Daiichi Sankyo
08-Nov-2019 Bavarian Nordic Announces Submission of European Marketing Authorisation Applications for Investigational Ebola Vaccine Regimen Bavarian Nordic A/S
08-Nov-2019 Bioeq announces Coherus as marketing and distribution partner for its biosimilar to Lucentis® (ranibizumab) in the U.S. Bioeq
08-Nov-2019 Immutep presents positive interim data from phase II TACTI-002 trial at SITC Immutep
08-Nov-2019 Mallinckrodt to Present at Jefferies London Healthcare Conference Mallinckrodt plc
08-Nov-2019 UKI2S wins Best Sector Support Organisation at the OBN Awards UKI2S
08-Nov-2019 OBN Awards 2019 – Winners Recognised at Industry Leading Event OBN
08-Nov-2019 OBN Awards 2019 - Winners Recognised at Industry Leading Event OBN
08-Nov-2019 RHÖN-KLINIKUM AG Confirms Guidance for 2019 Following Increase in Revenues in the Third Quarter and in the First Nine Months RHÖN-KLINIKUM AG
08-Nov-2019 Abcam and BrickBio Announce a Partnership to Incorporate Conjugation-Ready Sites into Recombinant Antibodies Across Abcam’s Portfolio B3C newswire
08-Nov-2019 Camurus Announces That FDA Grants Braeburn's Citizen Petition, Eliminating the Risk of Further Blocking of Brixadi(TM) From the US market Camurus AB
08-Nov-2019 Omega-3 Fatty-acid Enriched Parenteral Nutrition Improves Patient Outcomes Fresenius Kabi Deutschland GmbH